We are live on
!
Find out more
CWM
CIBC World Markets Portfolio holdings
AUM
$20.8B
This Fund
S&P 500
This Quarter
Est. Return
-3.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
-$4.36B
(-26%)
Cap. Flow
-$3.8B
Cap. Flow
% of AUM
-29.89%
Top 10 Holdings %
Top 10 Hldgs %
38.21%
Holding
1,893
New
568
Increased
757
Reduced
513
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$211M |
| 2 |
Crown Castle
CCI
|
+$52.2M |
| 3 |
Tesla
TSLA
|
+$46.6M |
| 4 |
XP
XP
|
+$25.2M |
| 5 |
EA
Electronic Arts
EA
|
+$22.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$587M |
| 2 |
Honeywell
HON
|
+$142M |
| 3 |
Mastercard
MA
|
+$126M |
| 4 |
Apple
AAPL
|
+$111M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.12% |
| 2 | Financials | 11.86% |
| 3 | Consumer Discretionary | 10.19% |
| 4 | Communication Services | 9.97% |
| 5 | Healthcare | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Perspective Therapeutics
CATX
$339M
| $25.5K | ﹤0.01% |
+11,995
| New | +$36K |
|
1777
ADC Therapeutics
ADCT
$144M
| $25.4K | ﹤0.01% |
+18,044
| New | +$30.7K |
|
1778
Rackspace Technology
RXT
$1.22B
| $25.3K | ﹤0.01% |
+14,993
| New | +$35.7K |
|
1779
Prime Medicine
PRME
$533M
| $25K | ﹤0.01% |
+12,585
| New | +$32.1K |
|
1780
PLAYSTUDIOS Inc
MYPS
$93.1M
| $24.8K | ﹤0.01% |
+19,534
| New | +$31.8K |
|
|
RGLS
1781
DELISTED
Regulus Therapeutics
RGLS
| $24.5K | ﹤0.01% |
+14,013
| New | +$18.5K |
|
1782
BRC Inc
BRCC
$241M
| $24.5K | ﹤0.01% |
+11,728
| New | +$29.9K |
|
1783
Nerdy
NRDY
$107M
| $24.5K | ﹤0.01% |
+17,243
| New | +$29K |
|
1784
NN Inc
NNBR
$298M
| $23.3K | ﹤0.01% |
+10,323
| New | +$29.6K |
|
1785
Alector
ALEC
$203M
| $22.4K | ﹤0.01% |
+18,195
| New | +$29.6K |
|
1786
SkinHealth Systems
SKIN
$99.5M
| $22.1K | ﹤0.01% |
+16,514
| New | +$25.2K |
|
1787
Stereotaxis
STXS
$135M
| $22.1K | ﹤0.01% |
+12,538
| New | +$26.7K |
|
1788
ProKidney
PROK
$337M
| $21.6K | ﹤0.01% |
24,700
+14,439
| +141% | +$20K |
|
|
MAPS
1789
DELISTED
WM TECHNOLOGY INC A
MAPS
| $21.6K | ﹤0.01% |
+19,122
| New | +$25.5K |
|
1790
Nkarta
NKTX
$164M
| $21.6K | ﹤0.01% |
+11,741
| New | +$24.1K |
|
1791
C4 Therapeutics
CCCC
$402M
| $21.4K | ﹤0.01% |
+13,347
| New | +$39.8K |
|
1792
Editas Medicine
EDIT
$445M
| $21.3K | ﹤0.01% |
+18,390
| New | +$27.1K |
|
1793
Zentalis Pharmaceuticals
ZNTL
$356M
| $20.2K | ﹤0.01% |
+12,680
| New | +$27.3K |
|
1794
Coherus Oncology
CHRS
$195M
| $20.1K | ﹤0.01% |
24,939
+14,527
| +140% | +$16.7K |
|
1795
Wheels Up
UP
$197M
| $20.1K | ﹤0.01% |
+995
| New | +$27.4K |
|
1796
Blink Charging
BLNK
$77.6M
| $19.6K | ﹤0.01% |
+21,348
| New | +$24.7K |
|
1797
Lyell Immunopharma
LYEL
$348M
| $19.2K | ﹤0.01% |
1,783
+1,031
| +137% | +$12.6K |
|
1798
Neumora Therapeutics
NMRA
$304M
| $18.9K | ﹤0.01% |
+18,911
| New | +$32.4K |
|
1799
Atossa Therapeutics
ATOS
$24.1M
| $18.9K | ﹤0.01% |
1,871
+1,082
| +137% | +$13.1K |
|
1800
GoPro
GPRO
$126M
| $18.8K | ﹤0.01% |
28,314
+16,602
| +142% | +$14.6K |
|
Similar funds
VRS
FAF
BGIM
CIM
PPFA
UOC
FNBT
CIBC World Markets's Q1 2025 Portfolio in Review
As of Q1 2025, CIBC World Markets held 1,893 positions worth $12.7B, down 26% from $17.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
CIBC World Markets withdrew a net $3.8B in Q1 2025, closing 51 positions and reducing 513 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, CIBC World Markets opened a new position in XP worth $25.2M.
- CIBC World Markets's largest Q1 2025 buy was XP: 1,832,600 shares worth $25.2M.
- CIBC World Markets added most to Microsoft in Q1 2025, an estimated $211M increase.
- CIBC World Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $587M.
- CIBC World Markets fully exited Apellis Pharmaceuticals in Q1 2025, selling an estimated $41M.
- CIBC World Markets's ten largest holdings make up 38% of its $12.7B portfolio in Q1 2025.
- CIBC World Markets opened 568 new positions and closed 51 in Q1 2025.
- CIBC World Markets's portfolio value fell 26% quarter-over-quarter to $12.7B.
Based on CIBC World Markets's 13F filing for Q1 2025, filed 13 May 2025.